The TAM model in the simulated tumor microenvironment was treated with dCP1 and dCPP, respectively, and it was found that glycopeptide can better reduce Mrc1 in M2-like TAM and increase the relative expression levels of IL-1β and IL-6 mRNA. Here, MRC1 is linked to neoplasm.